Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives
- PMID: 27440129
- PMCID: PMC5115149
- DOI: 10.21053/ceo.2015.01662
Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives
Abstract
Cholesteatoma is a cystic non tumorous lesion of the temporal bone that has the ability to destroy nearby structures by its power to cause bone resorption and as a result, fatal complications prevail. We aimed to conduct a comprehensive review for pathogenesis of acquired cholesteatoma, bone resorption mechanisms, and offer a future vision of this serious disease. We have reviewed different theories for pathogenesis of acquired cholesteatoma including the most relevant and updated ones with special emphasis on the mechanisms of bone resorption through Medline/PubMed research using the keywords 'aetiopathogenesis, bone resorption, acquired cholesteatoma, temporal bone, and cytokines.' In order to strengthen our study, we searched the reference lists of identified reviews. Cholesteatoma is a subject of debate among otolaryngologists since it was prescribed firstly. Over many decades, several theories were postulated for aetiopathogenesis of cholesteatoma with a tendency to follow more than one theory to explain the proper nature of that disease. Until now, the mechanism of bone resorption has yet to be more clarified. In the last century, a leap has occurred in the field of biomolecular cholesteatoma research which improved our knowledge about its pathophysiology and bone destructive mechanism. However, surgery is still the only available treatment. We conclude that discovery of new therapeutic choices for cholesteatoma other than surgery by the use of anti-growth, anti-proliferative, apoptotic agents as well as medications that antagonize osteoclastogenesis should be the main concern in the future clinical and experimental research work. Also, searching for predictors of the aggressiveness of cholesteatoma can affect the timing of intervention and prevent occurrence of complications.
Keywords: Acquired; Bone Resorption; Cholesteatoma; Cytokines; Pathogenesis; Temporal Bone.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
Similar articles
-
The role of bone resorption in the etiopathogenesis of acquired middle ear cholesteatoma.Eur Arch Otorhinolaryngol. 2017 May;274(5):2071-2078. doi: 10.1007/s00405-016-4422-6. Epub 2016 Dec 16. Eur Arch Otorhinolaryngol. 2017. PMID: 27981350 Review.
-
Cytokeratin 13, Cytokeratin 17, and Ki-67 Expression in Human Acquired Cholesteatoma and Their Correlation With Its Destructive Capacity.Clin Exp Otorhinolaryngol. 2017 Sep;10(3):213-220. doi: 10.21053/ceo.2016.01263. Epub 2017 Jan 12. Clin Exp Otorhinolaryngol. 2017. PMID: 28073243 Free PMC article.
-
Study of Angiogenic, Pro-Apoptotic, and Pro-Inflammatory Factors in Congenital and Acquired Cholesteatomas.J Pers Med. 2023 Jul 26;13(8):1189. doi: 10.3390/jpm13081189. J Pers Med. 2023. PMID: 37623440 Free PMC article.
-
Etiopathogenesis of cholesteatoma.Eur Arch Otorhinolaryngol. 2004 Jan;261(1):6-24. doi: 10.1007/s00405-003-0623-x. Epub 2003 Jun 27. Eur Arch Otorhinolaryngol. 2004. PMID: 12835944 Review.
-
Etiopathogenesis of acquired cholesteatoma: prominent theories and recent advances in biomolecular research.Laryngoscope. 2015 Jan;125(1):234-40. doi: 10.1002/lary.24890. Epub 2014 Aug 14. Laryngoscope. 2015. PMID: 25123251 Review.
Cited by
-
Association of Matrix Metalloproteinase-2 mRNA Expression with Subtypes of Pediatric Cholesteatoma.Biomed Res Int. 2021 Mar 10;2021:6644897. doi: 10.1155/2021/6644897. eCollection 2021. Biomed Res Int. 2021. PMID: 33778077 Free PMC article. Clinical Trial.
-
Mastoid obliteration and reconstruction techniques: A review of the literature.J Otol. 2021 Jul;16(3):178-184. doi: 10.1016/j.joto.2021.01.002. Epub 2021 Jan 9. J Otol. 2021. PMID: 34220986 Free PMC article. Review.
-
Hsa_circ_0074491 regulates the malignance of cholesteatoma keratinocytes by modulating the PI3K/Akt pathway by binding to miR-22-3p and miR-125a-5p: An observational study.Medicine (Baltimore). 2021 Sep 17;100(37):e27122. doi: 10.1097/MD.0000000000027122. Medicine (Baltimore). 2021. PMID: 34664835 Free PMC article.
-
Engineered oncolytic virus for the treatment of cholesteatoma: A pilot in vivo study.Laryngoscope Investig Otolaryngol. 2019 Oct 15;4(5):532-542. doi: 10.1002/lio2.307. eCollection 2019 Oct. Laryngoscope Investig Otolaryngol. 2019. PMID: 31637298 Free PMC article.
-
Comparison of changes in mitochondrial bioenergetics between keratinocytes in human external auditory canal skin and cholesteatomas from normoxia to hypoxia.Sci Rep. 2018 Jan 9;8(1):125. doi: 10.1038/s41598-017-18536-y. Sci Rep. 2018. PMID: 29317713 Free PMC article.
References
-
- Olszewska E, Wagner M, Bernal-Sprekelsen M, Ebmeyer J, Dazert S, Hildmann H, et al. Etiopathogenesis of cholesteatoma. Eur Arch Otorhinolaryngol. 2004 Jan;261(1):6–24. - PubMed
-
- Soldati D, Mudry A. Knowledge about cholesteatoma, from the first description to the modern histopathology. Otol Neurotol. 2001 Nov;22(6):723–30. - PubMed
-
- Kuo CL. Etiopathogenesis of acquired cholesteatoma: prominent theories and recent advances in biomolecular research. Laryngoscope. 2015 Jan;125(1):234–40. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources